Notice: Internet Explorer 11 users may encounter issues loading pages throughout the website. Please turn on IE-11’s compatibility mode while we work to resolve the issue.




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator


FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall

October 25, 2014

FDA MedWatch - Intravia Containers by Baxter: Recall - Particulate Matter


FDA MedWatch Intravia Containers by Baxter Recall



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Generic Drug Industry Proposal to Address Drug Shortages Gets FTC Approval

Friday, August 10, 2012

The Generic Pharmaceutical Association (GPhA) received a Federal Trade Commission (FTC) Advisory Opinion permitting a plan to address drug shortages to move forward.  The GPhA’s plan is titled the "Accelerated Recovery Initiative (ARI)," and it would operate by generic drug manufacturers communicating production details of critical drugs to health care technology company, IMS Health.  This information would be pooled together with other IMS Health market data and then shared with the Food and Drug Administration.  Reportedly, with this information, the FDA would have a comprehensive real time view of drug production in the generic market place and could work more quickly and efficiently to avert shortages.

The announcement of the FTC's Advisory Opinion citing no antitrust violations with this ARI plan comes in the wake of the recently passed "Food and Drug Administration Safety Act," which placed a high value on enhanced notification of drug shortages. 

More about drug shortages.

« Back to Washington Alerts